个人尼古丁药理动力学:一个受体意识的研究议程
Aaron L Nichols1, Christopher B Marotta2, Heather L Lukas3
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena CA 91125 USA.
概括
连续尼古丁监测器 (CNM) 可以跟踪个人尼古丁水平,帮助成研究和理解尼古丁.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
背景情况:
- 通过吸烟或蒸汽吸烟摄入尼古丁会在体内产生动态度变化.
- 了解这些尼古丁水平对于成研究和治疗开发至关重要.
- 尼古丁乙胆受体 (nAChRs) 受尼古丁度的影响,影响奖励和戒断.
研究的目的:
- 建议开发一种最少侵入性的连续尼古丁监测器 (CNM).
- 为了实时监测个人尼古丁度 ([尼古丁]t).
- 支持对尼古丁影响,成机制和治疗干预措施的研究.
主要方法:
- 使用间歇性液体作为监测的隔间.
- 探索基于光的传感器 (例如 iNicSnFRs) 和用于尼古丁检测的电化学方法.
- 将连续尼古丁测量与与nAChR功能相关的生理数据相关联.
主要成果:
- 一个CNM将提供有关在摄入期间和摄入后的动态[尼古丁]t的关键数据.
- 个人[尼古丁]t概况可以告知尼古丁替代疗法的有效性.
- 监测[尼古丁]t不能在体内阐明nAChR激活,脱敏和上调.
结论:
- 一个连续的尼古丁监测器对于个性化了解尼古丁的影响至关重要.
- 使用当前的传感器技术,开发一个具有成本效益的CNM (每24小时100美元以下) 是可行的.
- 建议提供公共资金来推进功能性CNM的研究议程.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Cholinergic Receptors: Nicotinic
2.1K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.1K
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K


